Advertisement
Screener

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

2.8 / 5 stars · 68/120 Roast Me

CLOVER HEALTH INVESTMENTS, CORP. /DE Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$85.55 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.

Financial Statements › Income Statement › Net Income

us-gaap:ProfitLoss · last filed 2026-02-27

  • CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$49.32M.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$24.38M.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-06-30 was -$10.58M, a 242.79% decline year-over-year.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-03-31 was -$1.27M.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$85.55M.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$43.01M.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$213.36M.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$339.57M.
Period endNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 2 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filedNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filedNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month as first filedNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed
2025-12-31-$49.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$73.70M
derived: sum of 2 quarters · filed 2026-02-27
-$84.28M
derived: sum of 3 quarters · filed 2026-02-27
-$85.55M
10-K · filed 2026-02-27
2025-09-30-$24.38M
10-Q · filed 2025-11-07
-$34.95M
derived: sum of 2 quarters · filed 2025-11-07
-$36.23M
10-Q · filed 2025-11-07
-$58.32M
derived: sum of 4 quarters · filed 2026-02-27
2025-06-30-$10.58M
10-Q · filed 2025-08-08
-$11.85M
10-Q · filed 2025-08-08
-$33.94M
derived: sum of 3 quarters · filed 2026-02-27
-$43.10M
derived: sum of 4 quarters · filed 2026-02-27
2025-03-31-$1.27M
10-Q · filed 2025-05-09
-$23.37M
derived: sum of 2 quarters · filed 2026-02-27
-$32.52M
derived: sum of 3 quarters · filed 2026-02-27
-$25.11M
derived: sum of 4 quarters · filed 2026-02-27
2024-12-31-$22.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$31.25M
derived: sum of 2 quarters · filed 2026-02-27
-$23.84M
derived: sum of 3 quarters · filed 2026-02-27
-$43.01M
10-K · filed 2026-02-27
2024-09-30-$9.15M
10-Q · filed 2025-11-07
-$1.75M
derived: sum of 2 quarters · filed 2025-11-07
-$20.92M
10-Q · filed 2025-11-07
-$91.39M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$7.41M
10-Q · filed 2025-08-08
-$11.76M
10-Q · filed 2025-08-08
-$82.23M
derived: sum of 3 quarters · filed 2026-02-27
-$123.70M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31-$19.17M
10-Q · filed 2025-05-09
-$89.64M
derived: sum of 2 quarters · filed 2026-02-27
-$131.11M
derived: sum of 3 quarters · filed 2026-02-27
-$159.93M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31-$70.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$111.94M
derived: sum of 2 quarters · filed 2026-02-27
-$140.75M
derived: sum of 3 quarters · filed 2026-02-27
-$213.36M
10-K · filed 2026-02-27
2023-09-30-$41.47M
10-Q · filed 2024-11-08
-$70.28M
derived: sum of 2 quarters · filed 2024-11-08
-$142.89M
10-Q · filed 2024-11-08
-$227.12M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30-$28.81M
10-Q · filed 2024-08-08
-$101.42M
10-Q · filed 2024-08-08
-$185.65M
derived: sum of 3 quarters · filed 2025-03-03
-$261.13M
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31-$72.61M
10-Q · filed 2024-05-07
-$156.83M
derived: sum of 2 quarters · filed 2025-03-03
-$232.32M
derived: sum of 3 quarters · filed 2025-03-03
-$336.68M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31-$84.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
-$159.72M
derived: sum of 2 quarters · filed 2025-03-03
-$264.08M
derived: sum of 3 quarters · filed 2025-03-03
-$339.57M
10-K · filed 2025-03-03
-$338.84M
10-K · filed 2023-03-01
2022-09-30-$75.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06
-$179.85M
derived: sum of 2 quarters · filed 2023-11-06
-$255.34M
10-Q · filed 2023-11-06
-$254.80M
10-Q · filed 2022-11-07
-$442.54M
derived: sum of 4 quarters · filed 2024-03-14
2022-06-30-$104.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$179.85M
10-Q · filed 2023-08-08
-$179.49M
10-Q · filed 2022-08-08
-$367.05M
derived: sum of 3 quarters · filed 2024-03-14
-$401.58M
derived: sum of 4 quarters · filed 2024-03-14
2022-03-31-$75.49M
10-Q · filed 2023-05-09
-$75.31M
10-Q · filed 2022-05-09
-$262.69M
derived: sum of 2 quarters · filed 2024-03-14
-$297.22M
derived: sum of 3 quarters · filed 2024-03-14
-$614.83M
derived: sum of 4 quarters · filed 2024-03-14
2021-12-31-$187.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
-$221.73M
derived: sum of 2 quarters · filed 2024-03-14
-$539.34M
derived: sum of 3 quarters · filed 2024-03-14
-$587.76M
10-K · filed 2024-03-14
2021-09-30-$34.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
-$352.14M
derived: sum of 2 quarters · filed 2022-11-07
-$400.56M
10-Q · filed 2022-11-07
-$526.95M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30-$317.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$366.03M
10-Q · filed 2022-08-08
-$492.42M
derived: sum of 3 quarters · filed 2023-03-01
-$479.66M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31-$48.42M
10-Q · filed 2022-05-09
-$174.81M
derived: sum of 2 quarters · filed 2023-03-01
-$162.05M
derived: sum of 3 quarters · filed 2023-03-01
-$156.65M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31-$126.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
-$113.63M
derived: sum of 2 quarters · filed 2023-03-01
-$108.23M
derived: sum of 3 quarters · filed 2023-03-01
-$136.39M
10-K · filed 2023-03-01
-$6.74M
10-K · filed 2021-03-31
2020-09-30$12.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$18.16M
derived: sum of 2 quarters · filed 2021-11-09
-$10.00M
10-Q · filed 2021-11-09
-$2.35M
10-Q · filed 2020-11-16
2020-06-30$5.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
-$22.76M
10-Q · filed 2021-08-11
-$56.56K
10-Q · filed 2020-08-13
2020-03-31-$28.16M
10-Q · filed 2021-05-17
2019-12-31-$17.63K
10-K · filed 2021-03-31
-$363.74M
10-K · filed 2022-02-28